Unknown

Dataset Information

0

Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype.


ABSTRACT: Elevated amino acid catabolism is common to many cancers. Here, we show that glioblastoma are excreting large amounts of branched-chain ketoacids (BCKAs), metabolites of branched-chain amino acid (BCAA) catabolism. We show that efflux of BCKAs, as well as pyruvate, is mediated by the monocarboxylate transporter 1 (MCT1) in glioblastoma. MCT1 locates in close proximity to BCKA-generating branched-chain amino acid transaminase 1, suggesting possible functional interaction of the proteins. Using in vitro models, we demonstrate that tumor-excreted BCKAs can be taken up and re-aminated to BCAAs by tumor-associated macrophages. Furthermore, exposure to BCKAs reduced the phagocytic activity of macrophages. This study provides further evidence for the eminent role of BCAA catabolism in glioblastoma by demonstrating that tumor-excreted BCKAs might have a direct role in tumor immune suppression. Our data further suggest that the anti-proliferative effects of MCT1 knockdown observed by others might be related to the blocked excretion of BCKAs.

SUBMITTER: Silva LS 

PROVIDER: S-EPMC5709768 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2022-10-04 | PXD032100 | Pride
2022-10-03 | MTBLS4497 | MetaboLights
| S-EPMC7960706 | biostudies-literature
| S-EPMC9313099 | biostudies-literature
| S-EPMC5419324 | biostudies-literature
| S-EPMC4784261 | biostudies-literature
| S-EPMC6344513 | biostudies-literature
| S-EPMC8112551 | biostudies-literature
| S-EPMC7518300 | biostudies-literature
| S-EPMC8363281 | biostudies-literature